DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
A podcast by DrugPatentWatch
100 Episodio
-
Indian Pharma—Some Challenges and Acceptances
Pubblicato: 21/12/2020 -
Essential Medicines and Patents
Pubblicato: 15/12/2020 -
Drug Patent Expirations for the Week of November 29, 2020
Pubblicato: 03/12/2020 -
New patent expiration for Cubist Pharms drug ENTEREG
Pubblicato: 29/11/2020 -
Thinking of signing your company up for DrugPatentWatch?
Pubblicato: 10/11/2020 -
Finding and Evaluating Generic Drug Market Entry Opportunities
Pubblicato: 06/10/2020 -
Freedom of Information Act Access to an Investigational New Drug Application
Pubblicato: 06/10/2020 -
Finding and Evaluating Generic Market Entry Opportunities
Pubblicato: 24/09/2020 -
Getting the most out of pharmaceutical patent-term extensions in Russia
Pubblicato: 22/09/2020 -
Switching to DrugPatentWatch
Pubblicato: 22/09/2020 -
Government as the First Investor in Biopharmaceutical Innovation
Pubblicato: 15/09/2020 -
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs
Pubblicato: 15/09/2020 -
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
Pubblicato: 02/09/2020 -
Drug Repurposing: An Overview
Pubblicato: 19/08/2020 -
Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider
Pubblicato: 19/08/2020 -
Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market
Pubblicato: 12/08/2020 -
Finding and Evaluating Market Entry Opportunities for a Better ROI
Pubblicato: 04/08/2020 -
Free Patent Litigation Docket Reports Data
Pubblicato: 30/07/2020 -
Free Orange Book PDF Library from DrugPatentWatch
Pubblicato: 24/07/2020 -
A comprehensive review of database resources in chemistry
Pubblicato: 16/07/2020
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
